Tinea clinical trials
The registry lists 88 studies for Tinea across more than 10 countries. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-11.
Status
- Completed
- 68
- Status unknown
- 7
- Not yet recruiting
- 4
- Terminated
- 4
- Withdrawn
- 2
- Recruiting
- 2
Phase
- Phase 3
- 29
- Phase 2
- 22
- Phase 1
- 13
- Phase 4
- 9
- Early Phase 1
- 2
Where
- United States
- 36
- Dominican Republic
- 9
- Puerto Rico
- 8
- Belize
- 7
- Honduras
- 7
- Brazil
- 5
Who runs them
Taro Pharmaceuticals USA (9) · Merz North America, Inc. (9) · AmDerma (4) · DermBiont, Inc. (3) · Medicis Global Service Corporation (3) · Novartis (2) · AI Labs Group S.L (2) · Padagis LLC (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 88 — search for more.
- Clinical, Dermoscopic, and Mycological Evaluations of Resistant DermatophytosisNot yet recruitingNCT077968541 country
- Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled TrailNot yet recruitingNCT07675239Phase 41 country
- Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea CorporisRecruitingNCT07342153Phase 41 country
- A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and CorporisRecruitingNCT07312604Not applicable1 country
- Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea PedisNot yet recruitingNCT06869681Phase 4
- Efficacy and Safety of Terbinafine and ItraconazoleNot yet recruitingNCT05881980Phase 2/3
- Combination of Oral Antifungal Treatment for Refractory DermatophytosisCompletedNCT07816510Not applicable1 country
- Comparative Study of Topical Oxiconazole 1% Cream Versus Clotrimazole 1% Cream in the Treatment of DermatophytosisCompletedNCT07718685Not applicable1 country
- Comparative Efficacy of Topical Oxiconazole Cream (1%) Versus Topical Clotrimazole Cream (1%) in the Treatment of Tinea CrurisAbstractCompletedNCT07441005Early Phase 11 country
- Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient CareCompletedNCT074289541 country
- Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT074289151 country
- Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton InfectionCompletedNCT07420894Not applicable1 country
- Evaluation of Two Dermatophyte qPCR Kits on Skin and Keratinous Samples.CompletedNCT072704711 country
- A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea PedisCompletedNCT04152226Phase 21 country
- Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution WorkingActive, not recruitingNCT06980493Phase 2/31 country
- Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea PedisCompletedNCT05363449Phase 11 country
- A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.CompletedNCT06305637Phase 11 country
- Use of Essential Oils as Natural TherapiesCompletedNCT05777525Phase 31 country
- A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea PedisStatus unknownNCT05493488Phase 21 country
- Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea PedisCompletedNCT03129321Phase 3
- A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea PedisCompletedNCT03897257Phase 22 countries
- Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea PedisCompletedNCT00804193Not applicable
- Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea PedisCompletedNCT00802672Phase 3
- Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisCompletedNCT02582177Phase 31 country
- A Study Of Diflucan In Children With Ringworm Of The ScalpCompletedNCT00645242Phase 32 countries
- A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. PedisTerminatedNCT04315051Phase 21 country
- A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.CompletedNCT04883593Early Phase 11 country
- Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry FeetCompletedNCT04265521Not applicable1 country
- Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea PedisTerminatedNCT02842021Phase 21 country
- A Therapeutic Equivalence Study of Ketoconazole Cream 2%CompletedNCT04203342Phase 32 countries
- Non-inferiority Trial of Dapaconazole Versus KetoconazoleCompletedNCT03320486Phase 31 country
- Study With Nåva Foot Cream in Patients With Tinea Pedis InterdigitalisCompletedNCT03676686Not applicable1 country
- Study Evaluating the Effect of Jublia on DermatophytomasCompletedNCT03098615Phase 41 country
- Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea CrurisCompletedNCT02767271Phase 42 countries
- Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea CrurisCompletedNCT02394340Phase 41 country
- Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea PedisStatus unknownNCT02882438Phase 11 country
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea PedisCompletedNCT03824912Phase 33 countries
- SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDISStatus unknownNCT03999437Phase 21 country
- SB208 for the Treatment of Tinea PedisCompletedNCT02860052Phase 21 country
- Senna Alata Leaf Decoction as a Treatment for Tinea ImbricataCompletedNCT03745183Not applicable
- Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea PedisCompletedNCT02335255Phase 1
- Evaluation of Trichoscopy in the Diagnosis of Tinea CapitisCompletedNCT02550496Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea PedisCompletedNCT01891305Phase 21 country
- Isotretinoin In Preventing Recurrences In Chronic Recurrent DermatophytosisStatus unknownNCT03471455Phase 2
- Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea CrurisCompletedNCT03359070Phase 21 country
- Three-Arm Trial of Novel Treatment for Tinea PedisCompletedNCT03135912Phase 21 country
- Terbinafine Compared to Griseofulvin in Children With Tinea CapitisCompletedNCT00117767Phase 31 country
- A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)CompletedNCT00509275Phase 12 countries
- BE Study of Naftifine HCLCompletedNCT02633813Phase 32 countries
- Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea PedisCompletedNCT02132260Phase 1